These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 28608153)
41. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Jain RK; Tong RT; Munn LL Cancer Res; 2007 Mar; 67(6):2729-35. PubMed ID: 17363594 [TBL] [Abstract][Full Text] [Related]
42. Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. Semino CE; Kamm RD; Lauffenburger DA Exp Cell Res; 2006 Feb; 312(3):289-98. PubMed ID: 16337626 [TBL] [Abstract][Full Text] [Related]
43. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis. Li R; Luo M; Ren M; Chen N; Xia J; Deng X; Zeng M; Yan K; Luo T; Wu J J Vasc Res; 2014; 51(2):110-7. PubMed ID: 24603119 [TBL] [Abstract][Full Text] [Related]
44. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin. Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795 [TBL] [Abstract][Full Text] [Related]
45. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Chetty C; Lakka SS; Bhoopathi P; Rao JS Int J Cancer; 2010 Sep; 127(5):1081-95. PubMed ID: 20027628 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac). Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068 [TBL] [Abstract][Full Text] [Related]
47. Effect of fluid friction on interstitial fluid flow coupled with blood flow through solid tumor microvascular network. Sefidgar M; Soltani M; Raahemifar K; Bazmara H Comput Math Methods Med; 2015; 2015():673426. PubMed ID: 25960764 [TBL] [Abstract][Full Text] [Related]
48. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. Vlahakis NE; Young BA; Atakilit A; Hawkridge AE; Issaka RB; Boudreau N; Sheppard D J Biol Chem; 2007 May; 282(20):15187-96. PubMed ID: 17363377 [TBL] [Abstract][Full Text] [Related]
49. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis. Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265 [No Abstract] [Full Text] [Related]
50. Interstitial flow regulates the angiogenic response and phenotype of endothelial cells in a 3D culture model. Kim S; Chung M; Ahn J; Lee S; Jeon NL Lab Chip; 2016 Oct; 16(21):4189-4199. PubMed ID: 27722679 [TBL] [Abstract][Full Text] [Related]
51. Angiogenic Sprouting Dynamics Mediated by Endothelial-Fibroblast Interactions in Microfluidic Systems. Walji N; Kheiri S; Young EWK Adv Biol (Weinh); 2021 Nov; 5(11):e2101080. PubMed ID: 34655165 [TBL] [Abstract][Full Text] [Related]
52. Flow shear stress regulates endothelial barrier function and expression of angiogenic factors in a 3D microfluidic tumor vascular model. Buchanan CF; Verbridge SS; Vlachos PP; Rylander MN Cell Adh Migr; 2014; 8(5):517-24. PubMed ID: 25482628 [TBL] [Abstract][Full Text] [Related]
53. Fluid pressure is a magnitude-dependent modulator of early endothelial tubulogenic activity: implications related to a potential tissue-engineering control parameter. Shin HY; Underwood RM; Fannon MW Tissue Eng Part A; 2012 Dec; 18(23-24):2590-600. PubMed ID: 22793042 [TBL] [Abstract][Full Text] [Related]
54. The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro. Casali BC; Gozzer LT; Baptista MP; Altei WF; Selistre-de-Araújo HS Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163668 [TBL] [Abstract][Full Text] [Related]
55. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk. Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058 [TBL] [Abstract][Full Text] [Related]
56. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Brudno Y; Ennett-Shepard AB; Chen RR; Aizenberg M; Mooney DJ Biomaterials; 2013 Dec; 34(36):9201-9. PubMed ID: 23972477 [TBL] [Abstract][Full Text] [Related]
57. Regulation of tumor invasion by interstitial fluid flow. Shieh AC; Swartz MA Phys Biol; 2011 Feb; 8(1):015012. PubMed ID: 21301060 [TBL] [Abstract][Full Text] [Related]
59. Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin. Papo N; Silverman AP; Lahti JL; Cochran JR Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14067-72. PubMed ID: 21825147 [TBL] [Abstract][Full Text] [Related]
60. Computational modelling suggests complex interactions between interstitial flow and tumour angiogenesis. Vilanova G; Burés M; Colominas I; Gomez H J R Soc Interface; 2018 Sep; 15(146):. PubMed ID: 30185542 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]